NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GeneOne Life Science Inc (KO: 011000)

 
011000 Technical Analysis
1
As on 16th Oct 2024 011000 STOCK Price closed @ 2420.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

011000STOCK Price

Open 2270.00 Change Price %
High 2485.00 1 Day N/A N/A
Low 2260.00 1 Week 0.00 0.00
Close 2420.00 1 Month 0.00 0.00
Volume 754565 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
KO Korea Most Active Stocks
002760 1415.00 %
002760 1415.00 %
096300 156.00 -6.02%
096300 156.00 -6.02%
005930 59500.00 %
004870 706.00 %
004870 706.00 %
027740 951.00 %
027740 951.00 %
034020 19460.00 %
 
KO Korea Top Gainers Stocks
520003 13020.00 1.20%
153360 2770.00 0.18%
153360 2770.00 0.18%
 
KO Korea Top Losers Stocks
009275 1800.00 -64.50%
009275 1800.00 -64.50%
016385 10450.00 -37.05%
016385 10450.00 -37.05%
096300 156.00 -6.02%
096300 156.00 -6.02%
950130 15200.00 -1.94%
950130 15200.00 -1.94%
 
 
011000
Daily Charts
011000
Intraday Charts
Whats New @
Bazaartrend
011000
Free Analysis
 
011000 Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
011000 Forecast October 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
011000 Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
011000 Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
GeneOne Life Science Inc ( KO Korea Symbol : 011000 )
Sector : Healthcare And Other Stocks in Same Sector
 
011000 Other Details
Segment EQ
Market Capital 1217022656512.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
011000 Address
011000
 
011000 Latest News
 
Your Comments and Response on GeneOne Life Science Inc
 
011000 Business Profile
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company also develops GLS-3000 and GLS-5310 for the treatment of SARS-CoV-2; GLS-5100 to treat VZV-Shingles; and GLS-5140 for the treatment of SFTS. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for Zika; and GLS-6150, which is in Phase I clinical trial for treatment of hepatitis C, as well as GLS-6100 that is in pre-clinical stage for hepatitis C. Further, the company, through its subsidiary, VGXI, Inc., engages in the cGMP production of nucleic acid-based products, including DNA plasmids and mRNA. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science, Inc. in April 2014. GeneOne Life Science, Inc. was founded in 1976 and is headquartered in Seoul, South Korea. Address: The Pinnacle Gangnam, Seoul, South Korea, 06060
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service